Skip to main content

Table 2 Base case cost-effectiveness results

From: A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury

Treatment Costs QALYs Incremental Costs Incremental QALYs ICER (QALY)
No tranexamic acid £16,019 3.0656    
Tranexamic acid £16,115 3.0854 £96.69 0.0198 £4,885